• Diastolic dysfunction following anthracycline-based chemotherapy in breast cancer patients: incidence and predictors 

      Serrano, José M.; González, Iria; Castillo, Silvia del; Muñiz, Javier; Morales, Luis J.; Moreno, Fernando; Jiménez, Rosa; Cristóbal, Carmen; Graupner, Catherine; Talavera, Pedro; Curcio, Alejandro; Martínez, Paula; Guerra, Juan A.; Alonso, Joaquin J (AlphaMed Press, 2015-07-16)
      [Abstract] INTRODUCTION: Cardiotoxicity represents a major limitation for the use of anthracyclines or trastuzumab in breast cancer patients. Data from longitudinal studies of diastolic dysfunction (DD) in this group ...